Northwire Canada EditionMonday, October 19, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Financings

Cannabix Technologies announces Non-Brokered LIFE Private Placement

By The Northwire Desk — AI Analysis Nov 07, 2025 · 16:30 BLO · 0.57 Cannabix Technologies Inc.
BLO · Price

Executive Summary

  • Cannabix Technologies Inc. announced a non‑brokered private placement of up to 4,255,319 units at C$0.47 per unit, targeting gross proceeds of $2 million CAD.
  • Each unit consists of one common share and half of a non‑transferable warrant (exercise price C$0.60, 24‑month term) with an acceleration clause tied to the share price.
  • Net proceeds will be used for manufacturing, inventory, product marketing, general & administrative expenses (including investor relations), and working capital.

Key Details

  • Units Offered: Minimum 2,127,659 units; maximum 4,255,319 units.
  • Price per Unit: C$0.47.
  • Aggregate Gross Proceeds: $1 million CAD minimum; up to $2 million CAD maximum.
  • Closing Date: On or about November 25, 2025, subject to approvals (including CSE).
  • Unit Composition: 1 common share + ½ of one non‑transferable common share purchase warrant.
  • Warrant Terms: Exercise price C$0.60 per share; exercisable for 24 months from issuance; includes acceleration right.
  • Acceleration Clause: If the closing price ≥ C$0.75 for 10 consecutive trading days, Company may accelerate warrant expiry to 30 calendar days after notice, terminating holder rights without compensation.
  • Insider Participation: Insiders may subscribe; deemed a related‑party transaction but expected to be exempt from MI 61‑101 valuation and minority approval thresholds (≤25% market cap).
  • Finder’s Fees: Up to 8% cash of gross proceeds plus Finder’s Units up to 10% of units sold; Finder’s Units include one share + ½ warrant with same terms as above.
  • Use of Proceeds: Funding manufacturing, inventory, product marketing, general & administrative expenses (including investor relations), and working capital.
  • Investor Participation Right: One existing investor has a contractual right until May 15, 2026 for future equity financings; waiver received indicating they will not exercise it in this offering.

Notable Quotes

  • “Rav Mlait”, CEO – signatory on behalf of the Board of Directors.
Read the original news release →

More from Cannabix Technologies Inc.

Jun 29, 2026 · 08:45

Cannabix scales its breath-based THC and alcohol screening hardware into global mining and industrial sectors, but revenue remains negligible against operating burn.

Production / Operations Jun 15, 2026 · 08:45

Cannabix Technologies Inc.

M&A / Property May 29, 2026 · 08:45

Cannabix Expands Australian Footprint as MBT Certification Progresses Amidst Volatility

Production / Operations May 13, 2026 · 08:45

Cannabix Secures UL/CSA Certs, Clears Path for Gov Tenders Amidst Steady Commercial Rollout

Regulatory May 04, 2026 · 08:45

Cannabix Executes Commercial Rollout Amidst Dilution Concerns

Production / Operations Apr 20, 2026 · 08:45

Cannabix Breath Test Gains Traction in US Manufacturing Sector Following Commercial Launch

M&A / Property